ArticleJournal of the American Chemical Society2024
Redox-Switchable Aromaticity in a Helically Extended Indeno[2,1-
Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- One-Shot Pd(II)-Catalyzed Multiple C-H Activation Enables Modular Construction of Fluorenylidene Oxindole-Based Multi(Polycyclic) Aromatic Enes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Overcrowded Alkene Photo-Redox-Switches Based on Quinolinium/Carbene Building Blocks.Angewandte Chemie (International ed. in English) · 2026Article
- Access to Fluorene-Fused Isoquinolones Containing an Axially Chiral Element via Cascade Bi-Annulation Reaction of Indene-Dienes.Precision chemistry · 2026Article
- Light-gated redox switching and actuation in polymer hydrogels.Nature communications · 2025Article
- Indeno[2,1-c]fluorene Quasi[8]circulenes Through Intramolecular Cyclization.Angewandte Chemie (International ed. in English) · 2025Article
- Chiral Induction and Memory via Supramolecular Deracemization.Angewandte Chemie (International ed. in English) · 2025Article
- Multi-State Redox and Light-Driven Switching of Pseudorotaxanation and Cation Shuttling.Journal of the American Chemical Society · 2025Article
- Perturbing Pentalene: Aromaticity and Antiaromaticity in a Non-Alternant Polycyclic Aromatic Hydrocarbon and BN-Heteroanalogues.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025Article
- Light, Switch, Action! The Influence of Geometrical Photoisomerization in an Adaptive Self-Assembled System.Journal of the American Chemical Society · 2024Article
- Mix and Match Tuning of the Conformational and Multistate Redox Switching Properties of an Overcrowded Alkene.Journal of the American Chemical Society · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular switches have received major attention to enable the reversible modulation of various molecular properties and have been extensively used as trigger elements in diverse fields, including molecular machines, responsive materials, and photopharmacology. Antiaromaticity is a fascinating property that has attracted not only significant fundamental interest but is also increasingly relevant in different applications, in particular organic (opto)electronics. However, designing systems in which (anti)aromaticity can be judiciously and reversibly switched ON and OFF remains challenging. Herein, we report a helicene featuring an indenofluorene-bridged bisthioxanthylidene as a novel switch wherein a simultaneous two-electron (electro)chemical redox process allows highly reversible modulation of its (anti)aromatic character. Specifically, the two thioxanthylidene rotors, attached to the initially aromatic indenofluorene scaffold via overcrowded alkenes, adopt an
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.